Full text
| |
| Author(s): |
Fernando Fumagalli
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | Ribeirão Preto. |
| Institution: | Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (PCARP/BC) |
| Defense date: | 2015-04-17 |
| Examining board members: |
Flavio da Silva Emery;
Antonio Carlos Bender Burtoloso
|
| Advisor: | Flavio da Silva Emery |
| Abstract | |
Heterocyclic molecules are very important class of compounds in biological processes and drugs designing. Among all of them, carbazoles show great applicability for treatment of several diseases, especially against cancer. Many carbazoles are natural products, and one of our interests is Clauraila A. This work is based on the Clauraila A structure to development of a library of carbazoles for biological applications. The optimal conditions of the Åkermark-Knölker cyclodehydrogenation of diarylamine was studied to obtaind the carbazole core. The diarylamines were obtained by the optimized Buchwald-Hartwig amination reaction. This synthetic strategy was used to obtain the range of carbazoles, with different substituents in good and moderate yields, including natural products 6-methoxymurrayanine and Clausenal. The overall yield obtained in the synthesis of the natural products were similar to those previously described in the literature, however, unlike the literature our synthesis involved a reduced number of steps to obtain the desired product. In the optimization step of Åkermark-Knölker reaction, we first applied palladium (II) acetylacetonate instead of palladium (II) acetate. Moreover, with the achieved results the possible mechanism of this reaction was proposed. Additionally, after several attempts, dimethylchromenos were obtained from aminophenols using prenal and phenylboronic acid, which will be useful in the synthesis of other carbazoles, such as Clauraila B. (AU) | |
| FAPESP's process: | 13/00727-8 - Medicinal Chemistry of Carbazole Alkaloids: Synthesis of claurailas and analogs targeting new antileishmanial compounds |
| Grantee: | Fernando Fumagalli |
| Support Opportunities: | Scholarships in Brazil - Master |